Artrya Ltd (AYA)

Currency in AUD
2.43
-0.02(-0.82%)
Delayed Data·

AYA Earnings

Latest Release
Aug 19, 2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
14K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2026-0.080/--14.00K/------Free Sign Up
12/2025-0.090/--14.00K/------Free Sign Up
06/2025-0.090/--15.00K/------Free Sign Up
12/2024-0.090/--13.00K/------Free Sign Up
12/2022-0.080/----/------Free Sign Up
06/2022-0.190/----/------Free Sign Up
12/2021-0.080/----/------Free Sign Up

All numbers in AUD

Artrya Ltd Earnings Call Summary for Q1/2027

  • Artrya signed 5-year deal with Huntsville Hospital, its largest customer, but shares fell 4.49% to $2.34 amid limited revenue conversion.
  • Q1 customer receipts totaled AUD 84K while operating cash outflows rose to AUD 7.3M from AUD 6.4M; cash reserves stood at AUD 67.2M.
  • Company raised CCTA scan exit run-rate guidance to 22K-23K for FY from prior 15K target, citing accelerated commercial traction.
  • Salix Coronary Flow submission delayed after clinical substudy inconsistencies found; additional reader study required before FDA filing.
  • Management prioritizes speeding customer go-lives and expanding usage; Phase 2 plaque pre-authorization automation expected within months.
Last Updated: 26/10/2026, 01:48
Read Full Transcript

FAQ

What Is Artrya's Earnings Per Share (TTM)?

The Artrya EPS (TTM) is -0.17.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.